Sebastian Pawlak

Sebastian Pawlak has extensive experience in biotechnology and molecular biology, currently serving as the Head of the Group of Biotechnology and Recombinant Proteins and Leader of the Proteomics Laboratory at Adamed Pharma since January 2009. In these roles, Sebastian Pawlak oversees downstream processes for therapeutic proteins, including CMC issues and technology transfer, while designing and characterizing proteins biophysically and biochemically. Prior experience includes positions as a Junior Project Manager focusing on novel protein carriers for cancer therapeutics, and various research roles at the Institute of Biochemistry and Biophysics PAS, the International Institute of Molecular and Cell Biology, and the National Institute of Public Health. Sebastian Pawlak holds a Ph.D. in Biochemistry and Molecular Biology from the Institute of Biochemistry and Biophysics PAS and a Master's degree in Biotechnology from the University of Warsaw.